<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR19">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Qiu</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Q</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>MZ</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>H</given-names>
   </name>
  </person-group>
  <article-title>Local therapy for Oligoprogressive disease in patients with advanced stage non-small-cell lung Cancer harboring epidermal growth factor receptor mutation</article-title>
  <source>Clin Lung Cancer</source>
  <year>2017</year>
  <volume>18</volume>
  <issue>6</issue>
  <fpage>e369</fpage>
  <lpage>e373</lpage>
  <pub-id pub-id-type="doi">10.1016/j.cllc.2017.04.002</pub-id>
  <?supplied-pmid 28465010?>
  <pub-id pub-id-type="pmid">28465010</pub-id>
 </element-citation>
</ref>
